BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 25861849)

  • 1. Establishment of a novel lectin-antibody ELISA system to determine core-fucosylated haptoglobin.
    Shimomura M; Nakayama K; Azuma K; Terao N; Nishino K; Takamatsu S; Nakano M; Takahashi S; Kobayashi Y; Murata K; Kamada Y; Miyoshi E
    Clin Chim Acta; 2015 Jun; 446():30-6. PubMed ID: 25861849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reevaluation of a lectin antibody ELISA kit for measuring fucosylated haptoglobin in various conditions.
    Kamada Y; Kinoshita N; Tsuchiya Y; Kobayashi K; Fujii H; Terao N; Kamihagi K; Koyama N; Yamada S; Daigo Y; Nakamura Y; Taniguchi N; Miyoshi E
    Clin Chim Acta; 2013 Feb; 417():48-53. PubMed ID: 23262369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reevaluation of Pholiota squarrosa lectin-reactive haptoglobin as a pancreatic cancer biomarker using an improved ELISA system.
    Kusama K; Okamoto Y; Saito K; Kasahara T; Murata T; Ueno Y; Kobayashi Y; Kamada Y; Miyoshi E
    Glycoconj J; 2017 Aug; 34(4):537-544. PubMed ID: 28455724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fucosylated haptoglobin is a novel type of cancer biomarker linked to the prognosis after an operation in colorectal cancer.
    Takeda Y; Shinzaki S; Okudo K; Moriwaki K; Murata K; Miyoshi E
    Cancer; 2012 Jun; 118(12):3036-43. PubMed ID: 22006099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific increase in serum core-fucosylated haptoglobin in patients with chronic pancreatitis.
    Ueda M; Kamada Y; Takamatsu S; Shimomura M; Maekawa T; Sobajima T; Fujii H; Nakayama K; Nishino K; Yamada M; Kobayashi Y; Kumada T; Ito T; Eguchi H; Nagano H; Miyoshi E
    Pancreatology; 2016; 16(2):238-43. PubMed ID: 26897254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical application of a lectin-antibody ELISA to measure fucosylated haptoglobin in sera of patients with pancreatic cancer.
    Matsumoto H; Shinzaki S; Narisada M; Kawamoto S; Kuwamoto K; Moriwaki K; Kanke F; Satomura S; Kumada T; Miyoshi E
    Clin Chem Lab Med; 2010 Apr; 48(4):505-12. PubMed ID: 20128732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haptoglobin phenotype is a critical factor in the use of fucosylated haptoglobin for pancreatic cancer diagnosis.
    Morishita K; Ito N; Koda S; Maeda M; Nakayama K; Yoshida K; Takamatsu S; Yamada M; Eguchi H; Kamada Y; Miyoshi E
    Clin Chim Acta; 2018 Dec; 487():84-89. PubMed ID: 30189188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum fucosylated haptoglobin as a novel prognostic biomarker predicting high-Gleason prostate cancer.
    Fujita K; Shimomura M; Uemura M; Nakata W; Sato M; Nagahara A; Nakai Y; Takamatsu S; Miyoshi E; Nonomura N
    Prostate; 2014 Jul; 74(10):1052-8. PubMed ID: 24802742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum fucosylated haptoglobin in chronic liver diseases as a potential biomarker of hepatocellular carcinoma development.
    Asazawa H; Kamada Y; Takeda Y; Takamatsu S; Shinzaki S; Kim Y; Nezu R; Kuzushita N; Mita E; Kato M; Miyoshi E
    Clin Chem Lab Med; 2015 Jan; 53(1):95-102. PubMed ID: 25060348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment of an antibody specific for cancer-associated haptoglobin: a possible implication of clinical investigation.
    Nishino K; Koda S; Kataoka N; Takamatsu S; Nakano M; Ikeda S; Kamamatsu Y; Morishita K; Moriwaki K; Eguchi H; Yamamoto E; Kikkawa F; Tomita Y; Kamada Y; Miyoshi E
    Oncotarget; 2018 Feb; 9(16):12732-12744. PubMed ID: 29560105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of fucosylated haptoglobin as a novel tumor marker for pancreatic cancer and its possible application for a clinical diagnostic test.
    Miyoshi E; Shinzaki S; Moriwaki K; Matsumoto H
    Methods Enzymol; 2010; 478():153-64. PubMed ID: 20816478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ELISA index of serum fucosylated haptoglobin for diagnosis of HCC using the normal and reverse AAL ELISA.
    Shang S; Qin X; Li W; Zhang S; Liu Y
    Discov Med; 2016 Jan; 21(113):15-23. PubMed ID: 26896598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Verification of the effectiveness of fucosylated haptoglobin as a pancreatic cancer marker in clinical diagnosis.
    Kuwatani M; Kawakami H; Kubota Y; Kawakubo K; Ito YM; Togo S; Ikeda T; Kusama K; Kobayashi Y; Murata T; Sakamoto N
    Pancreatology; 2019 Jun; 19(4):569-577. PubMed ID: 31031206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fucosylated haptoglobin is a novel marker for pancreatic cancer: detailed analyses of oligosaccharide structures.
    Miyoshi E; Nakano M
    Proteomics; 2008 Aug; 8(16):3257-62. PubMed ID: 18646007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycan array analysis of Pholiota squarrosa lectin and other fucose-oriented lectins.
    Rubén LC; Laura MR; Almudena FB; Emilio GM
    Glycobiology; 2021 May; 31(4):459-476. PubMed ID: 33021632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel core fucose-specific lectin from the mushroom Pholiota squarrosa.
    Kobayashi Y; Tateno H; Dohra H; Moriwaki K; Miyoshi E; Hirabayashi J; Kawagishi H
    J Biol Chem; 2012 Oct; 287(41):33973-82. PubMed ID: 22872641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis for specific recognition of core fucosylation in N-glycans by Pholiota squarrosa lectin (PhoSL).
    Yamasaki K; Kubota T; Yamasaki T; Nagashima I; Shimizu H; Terada RI; Nishigami H; Kang J; Tateno M; Tateno H
    Glycobiology; 2019 Jul; 29(7):576-587. PubMed ID: 30913288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum Fucosylated Haptoglobin as a Novel Diagnostic Biomarker for Predicting Hepatocyte Ballooning and Nonalcoholic Steatohepatitis.
    Kamada Y; Akita M; Takeda Y; Yamada S; Fujii H; Sawai Y; Doi Y; Asazawa H; Nakayama K; Mizutani K; Fujii H; Yakushijin T; Miyazaki M; Ezaki H; Hiramatsu N; Yoshida Y; Kiso S; Imai Y; Kawada N; Takehara T; Miyoshi E
    PLoS One; 2013; 8(6):e66328. PubMed ID: 23805214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Site-specific and linkage analyses of fucosylated N-glycans on haptoglobin in sera of patients with various types of cancer: possible implication for the differential diagnosis of cancer.
    Takahashi S; Sugiyama T; Shimomura M; Kamada Y; Fujita K; Nonomura N; Miyoshi E; Nakano M
    Glycoconj J; 2016 Jun; 33(3):471-82. PubMed ID: 26869352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of an antibody-lectin enzyme immunoassay for fucosylated α-fetoprotein.
    Korekane H; Hasegawa T; Matsumoto A; Kinoshita N; Miyoshi E; Taniguchi N
    Biochim Biophys Acta; 2012 Sep; 1820(9):1405-11. PubMed ID: 22233759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.